Products/Services Used | Details | Operation |
---|---|---|
Peptide Synthesis> | The LCMV-P14 TCR agonist peptide KAVYNFATM (GP33-41) and the OT-1 TCR agonist ovalbumin peptide SIINFEKL (N4), along with its variants EIINFEKL (E1), SIIGFEKL (G4), SIIVFEKL (V4), SIITFEKL (T4) and SIIQFEKL (Q4), were obtained from Genscript (Piscataway, NJ, USA). | Get A Quote |
T lymphocytes’ ability to discriminate between structurally related antigens has been attributed to the unique signaling properties of the T cell receptor. However, recent studies have suggested that the output of this discrimination process is conditioned by environmental cues. Here, we demonstrate how the IL-2 cytokine, collectively generated by strongly activated T cell clones, can induce weaker T cell clones to proliferate. We identify the PI3K pathway as being critical for integrating the antigen and cytokine responses and for controlling cell-cycle entry. We build a hybrid stochastic/deterministic computational model that accounts for such signal synergism and demonstrates quantitatively how T c... More